IP Verse

Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. vs Gilead Pharmasset LLC

The detailed information for PTAB case with proceeding number IPR2018-00125 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. against Gilead Pharmasset LLC on Oct 30, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00125
Filing Date
Oct 30, 2017
Petitioner
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al.
Respondent
Gilead Pharmasset LLC
Status
Institution Denied
Respondent Application Number
13738425
Respondent Tech Center
1600
Respondent Patent Number
8633309
Institution Decision Date
May 24, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Sep 17, 2018PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fees

Aug 3, 2018PAPERPETITIONER

Decision Denying Petitioner's Request for Rehearing

Jul 27, 2018PAPERBOARD

Petitioner's Request for Rehearing

Jun 25, 2018PAPERPETITIONER

Decision Denying Institution of Inter Partes Review

May 24, 2018PAPERBOARD

Patent Owner's Corrected Preliminary Response

Apr 4, 2018PAPERPATENT OWNER

Decision - Authorizing Corrected Patent Owner Preliminary Response - 37 CFR 42.5(a)

Apr 3, 2018PAPERBOARD

Ex. 3001

Apr 3, 2018EXHIBITBOARD

Michael J. Sofia, Nucleotide Prodrugs for HCV Therapy, 22 ANTIVIRAL CHEMISTRY and CHEMOTHERAPY 23-49 (2011)

Mar 19, 2018EXHIBITPATENT OWNER

Andrew Pollack, F.D.A. Approves Pill to Treat Hepatitis C, THE NEW YORK TIMES, 2013.

Mar 19, 2018EXHIBITPATENT OWNER

Donald Voet et al., FUNDAMENTALS OF BIOCHEMISTRY (3d ed. 2008).

Mar 19, 2018EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Mar 19, 2018PAPERPATENT OWNER

America¿¿¿s Overspend- How the Pharmaceutical Patent Problem is Fueling High Drug Prices, I-MAK (2017).

Mar 19, 2018EXHIBITPATENT OWNER

Our People, I-MAK (2018).

Mar 19, 2018EXHIBITPATENT OWNER

S. Zeuzem et al., Expert Opinion on the Treatment of Patients with Chronic Hepatitis C, 16 JOURNAL OF VIRAL HEPATITIS 75-90 (2009).

Mar 19, 2018EXHIBITPATENT OWNER

Michael J. Sofia et al., Discovery of a ¿¿-d-2-Deoxy-2¿¿¿-¿¿-fluoro-2-¿¿-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus, 53 JOURNAL OF MEDICINAL CHEMISTRY 7202-7218 (2010).

Mar 19, 2018EXHIBITPATENT OWNER

Miriam E. Tucker, FDA Approves Game Changer Hepatitis C Drug Sofosbuvir, MEDSCAPE, 2013.

Mar 19, 2018EXHIBITPATENT OWNER

Jonathan D. Rockoff, FDA Approves Gilead¿¿¿s Hepatitis C Drug. THE WALL STREET JOURNAL, 2013.

Mar 19, 2018EXHIBITPATENT OWNER

Eric Lawitz et al. Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection, 1358 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 56-67 (2014).

Mar 19, 2018EXHIBITPATENT OWNER

Lars P. Jordheim et al., Advances in the Development of Nucleoside and Nucleotide Analogues for Cancer and Viral Diseases, 12 NATURE REVIEWS 447-464 (2013).

Mar 19, 2018EXHIBITPATENT OWNER

OXFORD DICTIONARY OF BIOCHEMISTRY AND MOLECULAR BIOLOGY (rev. ed. 2000).

Mar 19, 2018EXHIBITPATENT OWNER

Larryn W. Peterson & Charles E. McKenna, Prodrug Approaches to Improving the Oral Absorption of Antiviral Nucleotide Analogues, 6 EXPERT OPINION ON DRUG DELIVERY 405-420 (2009).

Mar 19, 2018EXHIBITPATENT OWNER

IUPAC, COMPENDIUM OF CHEMICAL TERMINOLOGY: GOLD BOOK (2014).

Mar 19, 2018EXHIBITPATENT OWNER

Notice of Accord Filing Date

Dec 18, 2017PAPERBOARD

Patent Owner Gilead Pharmasset LLC Mandatory Notices

Nov 9, 2017PAPERPATENT OWNER

Gilead Pharmasset LLC Power of Attorney

Nov 9, 2017PAPERPATENT OWNER

Power of Attorney

Oct 30, 2017PAPERPETITIONER

Clark 147

Oct 30, 2017EXHIBITPETITIONER

Chapman

Oct 30, 2017EXHIBITPETITIONER

McGuigan 1994

Oct 30, 2017EXHIBITPETITIONER

Clark 2005

Oct 30, 2017EXHIBITPETITIONER

U.S. Patent No. 8,633,309

Oct 30, 2017EXHIBITPETITIONER

Curriculum Vitae of Joseph M. Fortunak, Ph.D.

Oct 30, 2017EXHIBITPETITIONER

File History Excerpts

Oct 30, 2017EXHIBITPETITIONER

Congiatu

Oct 30, 2017EXHIBITPETITIONER

Ma

Oct 30, 2017EXHIBITPETITIONER

Perrone

Oct 30, 2017EXHIBITPETITIONER

Byrn

Oct 30, 2017EXHIBITPETITIONER

Sofia 634

Oct 30, 2017EXHIBITPETITIONER

Declaration of Joseph M. Fortunak, Ph.D.

Oct 30, 2017EXHIBITPETITIONER

Petition for Inter Partes Review

Oct 30, 2017PAPERPETITIONER